Key facts
- Notable investors include Audacious Capital.
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Brazos Neuroscience
Funding rounds
1 roundsAbout Brazos Neuroscience
Developer of a blood-based diagnostic testing tool designed for evaluating mild-to-moderate traumatic brain injuries. The company's product analyzes glial and neuronal biomarkers along with genetic indicators to assess injury severity and recovery potential, enabling healthcare providers to diagnose and monitor brain injuries across clinical phases with objective data and personalized treatment decisions.
- Industry
- Diagnostic Equipment
- Sector
- Healthcare
- HQ
- Bellaire, TX, United States
- Founded
- 2019
- Website
- brazosneuro.health/
- Ownership
- Privately Held (backing)
Brazos Neuroscience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Brazos Neuroscience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Brazos Neuroscience in its N-PORT filings yet. We sweep new filings monthly.